life rx glp 1 GLP-1 Tone 🧬 Introducing Ease Rx™ GLP-1

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinsons disease progression over 96 weeks of treatment, according to a phase 3 study published in The Lancet

For readers interested in the broader connection between peptides, hormonal balance, energy, and skin aging during midlife transitions, this guide to peptides for perimenopause offers additional context

10.3389/fmolb.2021.707461 107 YamadaH.SuzukiK.FujiiR.KawadoM.HashimotoS.WatanabeY.et al (2021)

It is not known if Saxenda will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people

Original Medicare alone Parts A and B without a drug plan doesnt qualify

34 In the double-blind study, seven patients received subcutaneous exenatide twice daily and eight patients received placebo